Piero Perucca, MD, PhD, FRACP is Professor of Adult Epilepsy at the Department of Medicine (Austin Health), Melbourne Medical School, The University of Melbourne, and Director of the Bladin-Berkovic Comprehensive Epilepsy Program at Austin Health. He is also Adjunct Associate Professor at the Department of Neuroscience, School of Translational Medicine, Monash University, and holds honorary appointments at Alfred Health and The Royal Melbourne Hospital. 

He received his MD and Specialist-in-Neurology degrees from the University of Pavia, Italy. He undertook higher training in epileptology at the Neurological Institute of New York, Columbia University, USA; University Hospitals Cleveland Medical Center, Case Western Reserve University, USA; the Montreal Neurological Institute, McGill University, Canada; and the Royal Melbourne Hospital. He obtained his PhD from The University of Melbourne, with studies focused on the role of genetic factors in the aetiology of focal epilepsies and in the outcomes of epilepsy therapy.

His research program covers different areas of epileptology, including the genetics of epilepsy, electroencephalography, epilepsy and pregnancy, the pharmacological and surgical treatment of epilepsy, and genomic and electrophysiological biomarkers of epilepsy outcomes. He has published widely in the field of epilepsy, with publications in leading medical journals, such as The Lancet Neurology, Nature Reviews Disease Primers, Brain, Annals of Neurology, and Neurology. He has received several awards/prizes for his research, including the Michael Prize 2023 from the Michael Foundation, the 2022 Dreifuss-Penry Epilepsy Award from the American Academy of Neurology, and the 2021 Leonard Cox Award from the Australian and New Zealand Association of Neurologists.

He is Chair of the Victorian Epilepsy Centres and holds leadership positions in different international and national scientific organisations, including the International League Against Epilepsy, the American Epilepsy Society, and the Epilepsy Society of Australia. He also serves as an Associate Editor for Epilepsia Open and as an editorial board member for Neurobiology of Disease and Epigraph.